SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-022361
Filing Date
2022-08-12
Accepted
2022-08-12 16:16:14
Documents
67
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1497011
2 ex31.htm EX-31 34006
3 ex32.htm EX-32 8506
  Complete submission text file 0001493152-22-022361.txt   8015587

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT age-20220630.xsd EX-101.SCH 42717
5 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT age-20220630_cal.xml EX-101.CAL 63345
6 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT age-20220630_def.xml EX-101.DEF 181238
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT age-20220630_lab.xml EX-101.LAB 356962
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT age-20220630_pre.xml EX-101.PRE 289382
61 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1906157
Mailing Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501
Business Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38519 | Film No.: 221160293
SIC: 2834 Pharmaceutical Preparations